subject area of
- American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia Academic Article
- Argatroban Anticoagulant Therapy in Patients With Heparin-Induced Thrombocytopenia Academic Article
- Argatroban Anticoagulation in Patients With Heparin-Induced Thrombocytopenia Academic Article
- Argatroban anticoagulation in patients with a history of heparin-induced thrombocytopenia Academic Article
- Argatroban as a Heparin Substitute in Cases of Heparin-Induced Thrombocytopenia Academic Article
- Biosynthesis of the Piperidine Nucleus Academic Article
- Comment: Treatment of Heparin-Induced Thrombocytopenia Academic Article
- Comparison of argatroban and fondaparinux for the management of patients with isolated heparin-induced thrombocytopenia Academic Article
- Current agents for the treatment of patients with heparin-induced thrombocytopenia Academic Article
- Dabigatran and Argatroban Diametrically Modulate Thrombin Exosite Function Academic Article
- Differences in the clinically effective molar concentrations of four direct thrombin inhibitors explain their variable prothrombin time prolongation Academic Article
- Direct Thrombin Inhibitors in Cardiac Disease Academic Article
- Direct thrombin inhibitors in acute coronary syndromes: principal results of a meta-analysis based on individual patients' data Academic Article
- Fondaparinux versus direct thrombin inhibitor therapy for the management of heparin-induced thrombocytopenia (HIT) – Bridging the River Coumarin Academic Article
- General method for the determination of precursor configuration in biosynthetic precursor-product relations. Derivation of pipecolic acid from D-lysine, and of piperidine alkaloids from L-lysine Academic Article
- Heparin-Induced Thrombocytopenia Academic Article
- Heparin-Induced Thrombocytopenia Academic Article
- Heparin-induced thrombocytopenia in intensive care patients Academic Article
- Heparin-induced thrombocytopenia in the critical care setting: Diagnosis and management^ Academic Article
- High‐dose intravenous immunoglobulin to treat spontaneous heparin‐induced thrombocytopenia syndrome Academic Article
- Management of heparin-induced thrombocytopenia: a critical comparison of lepirudin and argatroban Academic Article
- Parenteral Anticoagulants Academic Article
- Parenteral Anticoagulants Academic Article
- Progressive, Fatal Thrombosis Associated With Heparin-Induced Thrombocytopenia After Cardiac Surgery Despite “Therapeutic” Anticoagulation With Argatroban: Potential Role for PTT and ACT Confounding Academic Article
- Seizures, headache and thrombocytopenia: diagnosis and treatment do not always come in a standard sequence Academic Article
- Systemic acquired resistance networks amplify airborne defense cues Academic Article
- The serological profile of fondaparinux-associated heparin-induced thrombocytopenia syndrome Academic Article
- Thrombotic End Point for Assessing Argatroban Therapy for Heparin-Induced Thrombocytopenia Academic Article
- Translational Success Stories Academic Article
- Treatment of Heparin-Induced Thrombocytopenia Academic Article
- Venous limb gangrene and fatal hemorrhage: Adverse consequences of hit “overdiagnosis” in a patient with antiphospholipid syndrome Academic Article
- Venous limb gangrene during overlapping therapy with warfarin and a direct thrombin inhibitor for immune heparin-induced thrombocytopenia Academic Article